Trial intelligence / Profile preview

Phase 2b study of M516102 in atopic dermatitis

jRCT2080221373Phase 2

Sponsor
Maruho Co., Ltd.
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing M516102 with Placebo (2 arms).

02

Drugs

M516102
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on jRCT2080221373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call